Award Data

The broader impact/commercial potential of this project is to develop and commercialize a fast charging battery which offers better safety with long cycle life compared to today’s lithium (Li)-ion batteries. In traditional batteries, fast charging can cause the battery to become dangerously hot (more than 60°C/140°F) and reduce the life of the battery to one or two charges. The proposed batter ...

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to improve data harnessing and real-time intelligent decision making. The proposed technology is a new reconfigurable computing platform capable of performing a variety of Artificial Intelligence (AI) tasks in a distributed and parallel manner to deliver the best performance at a lower cost ...

The broader impact / commercial potential of this Small Business Technology Transfer (STTR) Phase I project is to build a condition assessment and monitoring platform that leverages artificial intelligence (AI) for intelligent decision support to expedite diagnosis and facilitate personalized therapy solutions. Currently, patient history data is obtained verbally, and poor health communication bet ...

The broader impact of this Small Technology Transfer Research (STTR) Phase I project opens pathways to large-scale domestic manufacturing of low-cost energy infrastructure needed to facilitate the clean energy transition in the United States. The United States has a vast offshore wind energy resource that is nearly four times the nation's current electricity use. This enormous potential presents a ...

The broader impact/commercial potential of this Small Business Technology Transfer Program (STTR) Phase I project is to help women undergoing menopause. Most women undergo menopause, a complex biobehavioral life stage that spans one-third of their life, frequently accompanied by a complex array of symptoms affecting their health, quality of life, relationships, and productivity. The most common an ...

The broader impact /commercial potential of this Small Business Technology Transfer (STTR) Phase I project lies in the discovery and development of first-in-class therapeutics as an anti-viral treatment of COVID-19 viral infection. Within the proposed studies, cyclic peptide-based novel, effective anti-viral drug candidates will be identified. Compared to small molecule-based drugs, peptides will ...

The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is to enable the discovery of new therapeutics targeting G protein-coupled receptors (GCPRs). GPCRs are expressed in nearly every organ system, are accessible due to their location on the membrane and potential to elicit almost every signaling pathway. Drugs targeting GPCRs make up 35% of all ...

The broader impact of this Small Business Technology Transfer (STTR) Phase I project is the development of new approaches for remote assessment of respiratory function during pandemics. Current pulmonary assessment methods require in-clinic visits and they induce coughing and droplet formation, thereby increasing the risk of disease spread. To reduce transmission risk these assessments have been l ...

The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is to improve measurement science. Currently, special low-pressure chambers known as "vapor cells" are made by hand in a select number of precision glassblowing shops and suffer from poor dimensional reproducibility, low production capacity, irregular sizes, and variable vapor composition lead ...

The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is improved diagnosis of cardiovascular disease, the top cause of death globally, taking about 18 million lives each year. The proposed work will develop a contrast agent that improves the diagnostic value of magnetic resonance angiograms (MRA), by enhancing images of the vascular system, and ...